J Cardiovasc Electrophysiol
-
Publication Venue For
- Correlation between AV synchrony and device collected AM-VP sequence counter in atrioventricular synchronous leadless pacemakers: A real-world assessment.. 34:197-206. 2023
- Leadless pacemaker implantation after lead extraction for cardiac implanted electronic device infection.. 33:464-470. 2022
- Is there a mortality benefit of atrial fibrillation ablation?. 33:194-196. 2022
- Can catheter ablation of atrial fibrillation reverse heart failure with preserved ejection fraction?. 32:2368-2370. 2021
- The role of posterior wall isolation in catheter ablation of persistent atrial fibrillation.. 32:2567-2576. 2021
- Behavior of AV synchrony pacing mode in a leadless pacemaker during variable AV conduction and arrhythmias.. 32:1947-1957. 2021
- Renal denervation for the treatment of ventricular arrhythmias: A systematic review and meta-analysis.. 32:1430-1439. 2021
- Leadless pacemaker implant with concomitant atrioventricular node ablation: Experience with the Micra transcatheter pacemaker.. 32:832-841. 2021
- Procedure characteristics and outcomes of atrial fibrillation ablation procedures using cryoballoon versus radiofrequency ablation: A report from the GWTG-AFIB registry.. 32:248-259. 2021
- Healthcare utilization and cost in patients with atrial fibrillation and heart failure undergoing catheter ablation.. 31:3166-3175. 2020
- Patient-reported outcomes and subsequent management in atrial fibrillation clinical practice: Results from the Utah mEVAL AF program.. 31:3187-3195. 2020
- Collaborative care for the wearable cardioverter defibrillator patient: Getting the patient and medical team "vested and active".. 31:2509-2515. 2020
- Ablation of persistent atrial fibrillation: Challenges and solutions.. 31:1809-1821. 2020
- Hands on: How to approach patients undergoing lead extraction.. 31:1801-1808. 2020
- Implantable cardioverter-defibrillator lead revision following left ventricular assist device implantation.. 31:1509-1518. 2020
- Performance of a novel active fixation quadripolar left ventricular lead for cardiac resynchronization therapy: Attain Stability Quad Clinical Study results.. 31:1147-1154. 2020
- When ablating over epicardial fat, consider the path of least resistance!. 31:1125-1127. 2020
- Preprocedural computed tomography before cardiac implanted electronic device lead extraction: Indication, technique, and approach to interpretation.. 31:723-732. 2020
- Left atrial appendage closure: A therapy uniquely suited for specific populations of patients with atrial fibrillation.. 30:2968-2976. 2019
- Non-invasively quantified changes in left ventricular activation predict outcomes in patients undergoing cardiac resynchronization therapy.. 30:2475-2483. 2019
- Physicians' perceptions of shared decision-making for implantable cardioverter-defibrillators: Results of a physician survey.. 30:2420-2426. 2019
- Chromosome 4q25 variants and biomarkers of myocardial fibrosis in patients with atrial fibrillation.. 30:1904-1913. 2019
- Epicardial ganglionated plexus ablation: Safety considerations beyond the atria.. 30:2189-2190. 2019
- Watchman implantation in a patient with left atrial appendage thrombus.. 30:1694-1695. 2019
- Low lead one ratio predicts clinical outcomes in left bundle branch block.. 30:709-716. 2019
- Leadless pacemaker implant in patients with pre-existing infections: Results from the Micra postapproval registry.. 30:569-574. 2019
- The paradox of innovation with leadless pacing.. 29:1705-1706. 2018
- Effectiveness of high rate and delayed detection ICD programming by race: A MADIT-RIT substudy.. 29:1418-1424. 2018
- Peeling back of left bundle branch refractoriness facilitates mapping of a hemodynamically unstable atrial flutter.. 29:1319-1320. 2018
- Predicting AF recurrence after catheter ablation: Is it time to use the force?. 29:272-273. 2018
- Stellate ganglion blockade for the treatment of refractory ventricular arrhythmias: A systematic review and meta-analysis.. 28:1460-1467. 2017
- Do new tools help us identify substrate to target for ablation in ventricular tachycardia?. 28:1068-1069. 2017
- Treating cardiac dysrhythmias by targeting the neck: Off target or on the right track?. 28:909-911. 2017
- Autonomic Modulation for the Treatment of Ventricular Arrhythmias: Therapeutic Use of Percutaneous Stellate Ganglion Blocks.. 28:446-449. 2017
- Safety and Clinical Outcomes of Catheter Ablation of Atrial Fibrillation in Patients With Chronic Kidney Disease.. 28:39-48. 2017
- Sex Differences in Inappropriate ICD Device Therapies: MADIT-II and MADIT-CRT.. 28:94-102. 2017
- Impedance Guided Radiofrequency Ablation for Atrial Fibrillation: Something Old Is New Again.. 27:1399-1402. 2016
- Intermittent Capture of the Left Bundle With Permanent His Bundle Pacing: Mechanistic Insights and Implications for an Emerging Field.. 27:1344-1348. 2016
- The Risk of Sudden Cardiac Death in Mitral Valve Prolapse: Are All Patients Created Equal?. 27:469-470. 2016
- Transcatheter Leadless Pacemaker Implantation for Complete Heart Block Following CoreValve Transcatheter Aortic Valve Replacement.. 27:125-126. 2016
- Reduction in Inappropriate ICD Therapy in MADIT-RIT Patients Without History of Atrial Tachyarrhythmia.. 26:879-884. 2015
- Catheter ablation for ventricular tachycardia in patients with an implantable cardioverter defibrillator (CALYPSO) pilot trial.. 26:151-157. 2015
- Optimal management of Riata leads with no known electrical abnormalities or externalization: a decision analysis.. 26:184-191. 2015
- Feasibility of near real-time lesion assessment during radiofrequency catheter ablation in humans using acoustic radiation force impulse imaging.. 25:1275-1283. 2014
- Stability of rotors and focal sources for human atrial fibrillation: focal impulse and rotor mapping (FIRM) of AF sources and fibrillatory conduction.. 25:1284-1292. 2014
- Cardiac implantable electronic device removal in patients with left ventricular assist device associated infections.. 25:1199-1205. 2014
- Cardiac resynchronization therapy in patients with renal dysfunction: keep calm and carry on.. 25:1196-1198. 2014
- Initial independent outcomes from focal impulse and rotor modulation ablation for atrial fibrillation: multicenter FIRM registry.. 25:921-929. 2014
- Outcomes of atrioesophageal fistula following catheter ablation of atrial fibrillation treated with surgical repair versus esophageal stenting.. 25:579-584. 2014
- "Typical" cavotricuspid isthmus-dependent atrial flutter without the cava.. 25:103-104. 2014
- More bad news for cardiac resynchronization therapy in atrial fibrillation patients: what to do?. 24:1123-1124. 2013
- Left atrial remodeling: shape before size?. 24:760-761. 2013
- Age differences in the use of implantable cardioverter-defibrillators among older patients hospitalized with heart failure.. 24:664-671. 2013
- Disproportionate costs and charges for pediatric catheter ablation: supply and demand... or just supply?. 24:170-172. 2013
- Electrophysiology in China: a special supplement. Introduction.. 23 Suppl 1:S1. 2012
- Do ICD lead recalls affect physician--or patient--behavior? If not, why not?. 23:866-868. 2012
- Maximum voltage-guided catheter ablation of typical atrial flutter: making a good procedure even better?. 23:486-488. 2012
- Use of ventricular synchronized triggered atrial pacing to facilitate hemodynamic support during mapping and catheter ablation of ventricular vachycardia.. 22:1174-1178. 2011
- Cerebral magnetic resonance findings in asymptomatic patients after atrial fibrillation catheter ablation: cause for alarm or further study?. 22:969-972. 2011
- Pulmonary vein contraction before and after radiofrequency ablation for atrial fibrillation.. 22:169-174. 2011
- Prevalence and clinical characteristics associated with left atrial appendage thrombus in fully anticoagulated patients undergoing catheter-directed atrial fibrillation ablation.. 21:849-852. 2010
- The impact of new and emerging clinical data on treatment strategies for atrial fibrillation.. 21:946-958. 2010
- Optimal timing of implantable cardioverter-defibrillator implantation after myocardial infarction: a decision analysis.. 21:791-798. 2010
- Can we improve the identification of ventricular scar to guide substrate-based ventricular tachycardia ablation?. 21:685-687. 2010
- Paroxysmal high-grade atrioventricular block and syncope in a previously healthy child: what is the mechanism?. 21:585-587. 2010
- Remote monitoring of implantable cardioverter defibrillators versus quarterly device interrogations in clinic: results from a randomized pilot clinical trial.. 21:545-550. 2010
- Pearls for ablation in congenital heart disease.. 21:223-230. 2010
- Rationale and design for the Defibrillators to Reduce Risk by Magnetic Resonance Imaging Evaluation (DETERMINE) trial.. 20:982-987. 2009
- The variability of the electrical properties of the pulmonary veins.. 20:1046-1047. 2009
- Mode of induction of ventricular tachycardia and prognosis in patients with coronary disease: the Multicenter UnSustained Tachycardia Trial (MUSTT).. 20:850-855. 2009
- Arrhythmias in children having a single left superior vena cava and minimal structural heart disease.. 20:182-186. 2009
- Reduced ejection fraction, sudden cardiac death, and heart failure death in the mode selection trial (MOST): implications for device selection in elderly patients with sinus node disease.. 19:1160-1166. 2008
- Implantable cardioverter defibrillator therapy in patients with prior coronary revascularization in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).. 19:1059-1065. 2008
- Time dependence of arrhythmias in ICD patients.. 19:790-793. 2008
- Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial.. 19:720-724. 2008
- Cryoablation of accessory pathways: incremental insights on the way toward a therapeutic panacea?. 19:348-350. 2008
- Ethnicity and arrhythmia susceptibility.. 19:427-429. 2008
- Azimilide for the treatment of atrial fibrillation, atrial flutter, and paroxysmal supraventricular tachycardia: results of a randomized trial and insights on the concordance of symptoms and recurrent arrhythmias.. 19:172-177. 2008
- Incidence and predictors of sudden cardiac death in patients with diastolic heart failure.. 18:1231-1235. 2007
- Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: a MADIT-II substudy.. 18:833-838. 2007
- Action potential and QT prolongation not sufficient to cause Torsade de Pointes: role of action potential triangulation.. 18:204-205. 2007
- Ebstein's anomaly of the tricuspid valve: a Wolf(f) in sheep's clothing.. 17:1337-1339. 2006
- Cigarette smoking and the risk of supraventricular and ventricular tachyarrhythmias in high-risk cardiac patients with implantable cardioverter defibrillators.. 17:931-936. 2006
- Predicting appropriate shocks in patients with heart failure: Patient level meta-analysis from SCD-HeFT and MADIT II. 2017